Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

This company has been moved to the archive! The financial data has not been updated since February 15, 2024.

Enterprise Value (EV)

Microsoft Excel

Current Enterprise Value (EV)

Vertex Pharmaceuticals Inc., current enterprise value calculation

Microsoft Excel
Current share price (P) $426.29
No. shares of common stock outstanding 258,307,816
US$ in thousands
Common equity (market value)1 110,114,039
Add: Preferred stock, $0.01 par value; none issued and outstanding (per books)
Total equity 110,114,039
Add: Current finance lease liabilities (per books) 50,600
Add: Long-term finance lease liabilities (per books) 376,100
Total equity and debt 110,540,739
Less: Cash and cash equivalents 10,369,100
Less: Marketable securities 849,200
Enterprise value (EV) 99,322,439

Based on: 10-K (reporting date: 2023-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 426.29 × 258,307,816


Historical Enterprise Value (EV)

Vertex Pharmaceuticals Inc., EV calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Share price1, 2 $426.29 $297.40 $244.24 $210.50 $240.09
No. shares of common stock outstanding1 258,307,816 257,091,441 254,576,691 259,960,062 259,268,593
US$ in thousands
Common equity (market value)3 110,114,039 76,458,995 62,177,811 54,721,593 62,247,796
Add: Preferred stock, $0.01 par value; none issued and outstanding (book value)
Total equity 110,114,039 76,458,995 62,177,811 54,721,593 62,247,796
Add: Current finance lease liabilities (book value) 50,600 40,800 46,900 42,434 38,794
Add: Long-term finance lease liabilities (book value) 376,100 430,800 509,800 539,042 538,576
Total equity and debt 110,540,739 76,930,595 62,734,511 55,303,069 62,825,166
Less: Cash and cash equivalents 10,369,100 10,504,000 6,795,000 5,988,187 3,109,322
Less: Marketable securities 849,200 274,500 729,900 670,710 698,972
Enterprise value (EV) 99,322,439 66,152,095 55,209,611 48,644,172 59,016,872

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Vertex Pharmaceuticals Inc. Annual Report.

3 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 426.29 × 258,307,816

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Vertex Pharmaceuticals Inc. EV increased from 2021 to 2022 and from 2022 to 2023.